The Global Aptamers Market Driven by Rising Research and Development
The Global aptamers market is estimated to be valued at US$ 7217.85 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Key Takeaways:
Key players operating in the aptamers market are ZOLL Medical Corporation, Stryker, Brunswick MedTech, Michigan Instruments, SunLife Sciences Pvt Ltd., CPR Medical Devices, Inc., Medtronic, Faith Group, Nihon Kohden Corporation, SCHILLER Americas Inc. The demand for aptamers is growing owing to their wide applications in diagnostics, research, therapeutics and other industrial applications. The market players are also expanding their presence globally to tap the opportunities offered by developing economies in the aptamers market.
The increasing R&D investments in life science research and clinical diagnostics is one of the major drivers of the global aptamers market. Pharmaceutical and biotechnology companies are actively funding for development of aptamers-based diagnostic kits and therapeutics. Additionally, the rising prevalence of chronic and infectious diseases worldwide has accelerated clinical research on disease biomarkers and drug discovery, thereby propelling the demand for aptamers.
Market drivers:
The Global Aptamers Market Demand is driven by the rising research and development activities in the pharmaceutical and biotechnology sectors. There is significant funding from government and private investors for development of aptamer-based point-of-care testing kits, targeted drug delivery systems and therapeutics. Aptamers provide an effective solution for early disease diagnosis and precision medicine. This is expected to witness wider uptake of aptamers during the forecast period.
Explore more information on this topic, Please visit -
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian